Seong-Wook Lee

Dr. Lee found Rznomics Inc., RNA-based biopharmaceutical company, in 2017 and has served as President and CEO. Dr. Lee is also currently a full Professor at Dankook University in Korea since 1997. He received the B.Sc. and M.Sc. degrees in Dept. of Microbiology from Seoul National University and obtained Ph.D. degree in Dept. of Molecular Biology at Cornell University. He was working as a graduate research assistant in Memorial Sloan-Kettering Cancer Center and as a research associate and a visiting scholar in Duke University Medical Center. His areas of expertise include development of RNAs as gene therapeutics as well as diagnostics. Especially, he has focused on developing RNAs for the treatment and prevention of diverse intractable diseases including genetic, infectious, degenerative, and malignant diseases. He serves now as an editorial board member of renowned international journals especially in the field of nucleic acid gene therapy including ‘Nucleic Acid Therapeutics’ and ‘Molecular Therapy-Nucleic Acids’. He served as President of ‘Korean Society of Gene and Cell Therapy’.